IP Library Granted Patent US 11,904,125
Granted Patent B2
US 11,904,125 · App. 16/893,922 · Granted Feb 20, 2024

Manuka honey microneedle

Inventors: Galit Frydman (Boston, MA); David Olaleye (Indianapolis, IN); Illina Yang (Sunnyvale, CA); Damodaran Annamalai (Norwood, MA)
Assignee: Massachusetts Institute of Technology
A61M37/0015A61K35/644A61P17/02A61P31/04A61K45/06A61M2037/0023A61M2037/0046A61M2037/0053A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,904,125
App. No.
16/893,922
Granted
Feb 20, 2024
Kind
B2
Abstract

A device, comprising a base, and a plurality of microneedles attached to the base, wherein the microneedles comprise dehydrated honey having water content of less than 5% by weight. The dehydrated honey can be a Manuka dehydrated honey. Also disclosed are methods of fabricating and using the disclosed device.

Claims (12)

1. A device, comprising a base, and a plurality of microneedles attached to the base, wherein:

the microneedles comprise dehydrated honey having water content of not greater than 1% by weight; and the honey is dehydrated by vacuum treatment.

2. The device of claim 1 , wherein the base comprises dehydrated honey having water content of less than 1% by weight.

3. The device of claim 1 , wherein the dehydrated honey has water content not greater than 0.5%.

4. The device of claim 1 , wherein the microneedles further include a water-soluble polymer material, wherein the polymer material is mixed with the dehydrated honey.

5. The device of claim 1 , wherein the microneedles include a scaffold material, wherein the scaffold material is coated with the dehydrated honey.

6. The device of claim 1 , wherein the base is composed of the dehydrated honey.

7. The device of claim 1 , wherein the device includes at least one additional active pharmaceutical ingredient (API).

8. The device of claim 7 , wherein the additional API is selected from a phage, an antiviral agent, an antifungal agent, an anti-parasitic agent, an antibacterial agent, a chemotherapeutic agent, an antibody, a cytokine, a growth factor, hormone, a vaccine, a nucleic acid, a nucleic acid modifying agent, a nutraceutical agent, an anesthetic, a sedative, or a narcotic-blocking or narcotic-reversing agent.

9. The device of claim 7 , wherein the additional API is a peptide or a protein.

10. The device of claim 1 , further including a substrate layer disposed on the base.

11. The device of claim 1 , wherein the dehydrated honey is a dehydrated Manuka honey.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2023
From: FRYDMAN, GALIT; OLALEYE, DAVID; YANG, ILLINA; ANNAMALAI, DAMODARAN
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 065482/0607 →
CONFIRMATORY LICENSE Recorded Oct 2, 2023
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065091/0626 →
Continuity (2)
Provisional Application 62858638 · Jun 7, 2019
Related Publication 20200384254A1 · Dec 10, 2020